 Drew Kern
Concepts (161)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Deep Brain Stimulation | 14 | 2023 | 72 | 5.100 |
Why?
| | Parkinson Disease | 21 | 2023 | 345 | 4.550 |
Why?
| | Subthalamic Nucleus | 7 | 2023 | 39 | 2.440 |
Why?
| | Tremor | 5 | 2023 | 45 | 1.260 |
Why?
| | Globus Pallidus | 2 | 2021 | 17 | 0.890 |
Why?
| | Dystonia | 3 | 2020 | 16 | 0.880 |
Why?
| | Thalamus | 2 | 2021 | 74 | 0.850 |
Why?
| | Methylphenidate | 1 | 2022 | 36 | 0.790 |
Why?
| | Dystonic Disorders | 1 | 2021 | 16 | 0.770 |
Why?
| | Zona Incerta | 1 | 2021 | 2 | 0.750 |
Why?
| | Caudate Nucleus | 1 | 2020 | 14 | 0.710 |
Why?
| | Putamen | 1 | 2020 | 14 | 0.710 |
Why?
| | NAV1.1 Voltage-Gated Sodium Channel | 1 | 2019 | 15 | 0.670 |
Why?
| | Parkinsonian Disorders | 1 | 2019 | 28 | 0.650 |
Why?
| | Dopaminergic Neurons | 1 | 2019 | 43 | 0.640 |
Why?
| | Epilepsies, Myoclonic | 1 | 2019 | 41 | 0.630 |
Why?
| | Leucine-Rich Repeat Serine-Threonine Protein Kinase-2 | 4 | 2018 | 10 | 0.590 |
Why?
| | Palatal Muscles | 1 | 2015 | 2 | 0.500 |
Why?
| | Behavior Therapy | 1 | 2015 | 225 | 0.420 |
Why?
| | Cell Adhesion Molecules, Neuronal | 1 | 2010 | 35 | 0.350 |
Why?
| | tau Proteins | 1 | 2010 | 66 | 0.340 |
Why?
| | Serine Endopeptidases | 1 | 2010 | 101 | 0.340 |
Why?
| | Extracellular Matrix Proteins | 1 | 2010 | 126 | 0.330 |
Why?
| | Neural Stem Cells | 1 | 2010 | 113 | 0.330 |
Why?
| | Nerve Tissue Proteins | 1 | 2010 | 527 | 0.270 |
Why?
| | Treatment Outcome | 5 | 2022 | 9049 | 0.270 |
Why?
| | Hippocampus | 1 | 2010 | 690 | 0.260 |
Why?
| | Humans | 29 | 2023 | 114039 | 0.260 |
Why?
| | Down Syndrome | 1 | 2010 | 335 | 0.250 |
Why?
| | Nervous System Diseases | 1 | 2007 | 254 | 0.230 |
Why?
| | Mutation | 4 | 2018 | 3338 | 0.230 |
Why?
| | Male | 17 | 2021 | 55392 | 0.220 |
Why?
| | Arm | 2 | 2018 | 104 | 0.220 |
Why?
| | Multiple System Atrophy | 1 | 2023 | 4 | 0.210 |
Why?
| | Serine | 3 | 2018 | 125 | 0.210 |
Why?
| | Intralaminar Thalamic Nuclei | 1 | 2022 | 3 | 0.200 |
Why?
| | Middle Aged | 9 | 2021 | 26601 | 0.190 |
Why?
| | Tic Disorders | 1 | 2021 | 6 | 0.190 |
Why?
| | Fluvoxamine | 1 | 2021 | 12 | 0.180 |
Why?
| | Serotonin Antagonists | 1 | 2021 | 30 | 0.180 |
Why?
| | Risperidone | 1 | 2021 | 26 | 0.180 |
Why?
| | Polyethylene Glycols | 3 | 2011 | 561 | 0.180 |
Why?
| | Dystonia Musculorum Deformans | 1 | 2020 | 3 | 0.180 |
Why?
| | Obsessive-Compulsive Disorder | 1 | 2021 | 32 | 0.180 |
Why?
| | Antidepressive Agents, Second-Generation | 1 | 2021 | 38 | 0.180 |
Why?
| | Voice Disorders | 1 | 2020 | 20 | 0.180 |
Why?
| | Brain | 5 | 2022 | 2355 | 0.180 |
Why?
| | Electric Impedance | 1 | 2020 | 100 | 0.170 |
Why?
| | Glycine | 2 | 2018 | 152 | 0.170 |
Why?
| | alpha-Synuclein | 2 | 2023 | 21 | 0.170 |
Why?
| | Hypokinesia | 1 | 2020 | 7 | 0.170 |
Why?
| | Leg | 1 | 2001 | 224 | 0.170 |
Why?
| | Atrophy | 1 | 2020 | 152 | 0.170 |
Why?
| | Neuroglia | 2 | 2011 | 149 | 0.170 |
Why?
| | Health Literacy | 1 | 2022 | 160 | 0.170 |
Why?
| | Tubulin | 1 | 2020 | 122 | 0.170 |
Why?
| | Autistic Disorder | 1 | 2021 | 160 | 0.160 |
Why?
| | Epileptic Syndromes | 1 | 2019 | 66 | 0.150 |
Why?
| | Biological Variation, Individual | 1 | 2018 | 2 | 0.150 |
Why?
| | Voice | 1 | 2018 | 8 | 0.150 |
Why?
| | Neuropsychological Tests | 1 | 2022 | 926 | 0.150 |
Why?
| | Spasms, Infantile | 1 | 2019 | 103 | 0.150 |
Why?
| | Depressive Disorder, Major | 1 | 2021 | 301 | 0.140 |
Why?
| | Actigraphy | 1 | 2018 | 75 | 0.140 |
Why?
| | Sex Characteristics | 2 | 2017 | 636 | 0.140 |
Why?
| | Family Health | 1 | 2018 | 193 | 0.140 |
Why?
| | REM Sleep Behavior Disorder | 1 | 2016 | 10 | 0.140 |
Why?
| | Disabled Persons | 1 | 2017 | 130 | 0.130 |
Why?
| | Biocompatible Materials | 2 | 2010 | 372 | 0.120 |
Why?
| | Adult | 7 | 2021 | 30371 | 0.120 |
Why?
| | Aged | 8 | 2019 | 18969 | 0.120 |
Why?
| | Physical Therapy Modalities | 1 | 2017 | 265 | 0.120 |
Why?
| | Female | 12 | 2020 | 59321 | 0.110 |
Why?
| | Reproducibility of Results | 1 | 2021 | 2764 | 0.110 |
Why?
| | Heart Diseases | 1 | 2017 | 329 | 0.110 |
Why?
| | Heart Rate | 1 | 2017 | 710 | 0.110 |
Why?
| | Colon | 1 | 2015 | 232 | 0.110 |
Why?
| | Hydrogels | 2 | 2010 | 573 | 0.100 |
Why?
| | Muscle, Skeletal | 1 | 2001 | 1468 | 0.100 |
Why?
| | Healthcare Disparities | 1 | 2017 | 479 | 0.100 |
Why?
| | Patient Acceptance of Health Care | 1 | 2017 | 675 | 0.100 |
Why?
| | Time Factors | 2 | 2020 | 6077 | 0.100 |
Why?
| | Biopsy | 1 | 2015 | 1024 | 0.090 |
Why?
| | Glial Cell Line-Derived Neurotrophic Factor | 1 | 2011 | 16 | 0.090 |
Why?
| | Polyglycolic Acid | 1 | 2011 | 43 | 0.090 |
Why?
| | Magnetic Resonance Imaging | 1 | 2021 | 3039 | 0.090 |
Why?
| | Hydrogel, Polyethylene Glycol Dimethacrylate | 1 | 2011 | 72 | 0.090 |
Why?
| | Intestinal Mucosa | 1 | 2015 | 532 | 0.090 |
Why?
| | Brain-Derived Neurotrophic Factor | 1 | 2011 | 106 | 0.090 |
Why?
| | Trisomy | 1 | 2010 | 68 | 0.090 |
Why?
| | Prospective Studies | 1 | 2021 | 6195 | 0.080 |
Why?
| | Lactic Acid | 1 | 2011 | 272 | 0.080 |
Why?
| | Movement Disorders | 1 | 2007 | 48 | 0.070 |
Why?
| | Aged, 80 and over | 4 | 2018 | 6306 | 0.070 |
Why?
| | Mice, Transgenic | 1 | 2010 | 1947 | 0.060 |
Why?
| | Alzheimer Disease | 1 | 2010 | 442 | 0.060 |
Why?
| | Combined Modality Therapy | 1 | 2007 | 1117 | 0.060 |
Why?
| | Young Adult | 2 | 2020 | 10442 | 0.060 |
Why?
| | Patient Selection | 1 | 2007 | 629 | 0.060 |
Why?
| | Epilepsy | 1 | 2007 | 278 | 0.050 |
Why?
| | Beta Rhythm | 1 | 2023 | 9 | 0.050 |
Why?
| | Basal Ganglia | 1 | 2023 | 44 | 0.050 |
Why?
| | Cells, Cultured | 1 | 2010 | 3861 | 0.050 |
Why?
| | Nerve Degeneration | 1 | 2023 | 41 | 0.050 |
Why?
| | Proof of Concept Study | 1 | 2022 | 47 | 0.050 |
Why?
| | Medicare | 2 | 2017 | 661 | 0.050 |
Why?
| | Retrospective Studies | 1 | 2019 | 12520 | 0.050 |
Why?
| | Upper Extremity | 1 | 2022 | 83 | 0.050 |
Why?
| | Wakefulness | 1 | 2022 | 128 | 0.050 |
Why?
| | Disease Models, Animal | 1 | 2010 | 3498 | 0.050 |
Why?
| | Aging | 1 | 2010 | 1611 | 0.040 |
Why?
| | Muscle Fibers, Skeletal | 1 | 2001 | 185 | 0.040 |
Why?
| | Electromyography | 1 | 2001 | 326 | 0.040 |
Why?
| | Biomechanical Phenomena | 1 | 2022 | 669 | 0.040 |
Why?
| | Mental Disorders | 1 | 2007 | 889 | 0.040 |
Why?
| | Prosthesis Implantation | 2 | 2011 | 138 | 0.040 |
Why?
| | Pedigree | 1 | 2020 | 460 | 0.040 |
Why?
| | Fingers | 1 | 2020 | 81 | 0.040 |
Why?
| | Severity of Illness Index | 2 | 2017 | 2537 | 0.040 |
Why?
| | Astrocytes | 2 | 2011 | 159 | 0.040 |
Why?
| | Microglia | 2 | 2011 | 198 | 0.040 |
Why?
| | Muscle Contraction | 1 | 2001 | 388 | 0.040 |
Why?
| | Skin | 1 | 2023 | 653 | 0.040 |
Why?
| | Pilot Projects | 1 | 2023 | 1360 | 0.040 |
Why?
| | Cohort Studies | 2 | 2018 | 4882 | 0.040 |
Why?
| | Geography, Medical | 1 | 2017 | 10 | 0.040 |
Why?
| | Movement | 1 | 2020 | 242 | 0.040 |
Why?
| | Referral and Consultation | 1 | 2022 | 631 | 0.040 |
Why?
| | Animals | 4 | 2011 | 31565 | 0.030 |
Why?
| | Dreams | 1 | 2016 | 10 | 0.030 |
Why?
| | Energy Metabolism | 1 | 2001 | 727 | 0.030 |
Why?
| | Patient Care Team | 1 | 2021 | 517 | 0.030 |
Why?
| | Biomarkers | 2 | 2018 | 3397 | 0.030 |
Why?
| | Comorbidity | 1 | 2021 | 1447 | 0.030 |
Why?
| | Polysomnography | 1 | 2016 | 136 | 0.030 |
Why?
| | Rats, Sprague-Dawley | 2 | 2011 | 2182 | 0.030 |
Why?
| | Sleep Deprivation | 1 | 2018 | 167 | 0.030 |
Why?
| | Anxiety | 1 | 2022 | 843 | 0.030 |
Why?
| | Paraffin Embedding | 1 | 2015 | 21 | 0.030 |
Why?
| | Genetic Association Studies | 1 | 2017 | 339 | 0.030 |
Why?
| | Mice | 1 | 2010 | 14841 | 0.030 |
Why?
| | Family | 1 | 2018 | 589 | 0.030 |
Why?
| | Electrocardiography | 1 | 2017 | 561 | 0.030 |
Why?
| | Polymorphism, Single Nucleotide | 1 | 2020 | 1880 | 0.030 |
Why?
| | Adolescent | 2 | 2020 | 17798 | 0.030 |
Why?
| | Rats | 2 | 2011 | 4913 | 0.030 |
Why?
| | Logistic Models | 1 | 2017 | 1829 | 0.030 |
Why?
| | Prevalence | 1 | 2017 | 2246 | 0.020 |
Why?
| | United States | 2 | 2017 | 12136 | 0.020 |
Why?
| | Incidence | 1 | 2017 | 2313 | 0.020 |
Why?
| | Quality of Life | 1 | 2022 | 2343 | 0.020 |
Why?
| | Immunohistochemistry | 1 | 2015 | 1624 | 0.020 |
Why?
| | Sensitivity and Specificity | 1 | 2015 | 1690 | 0.020 |
Why?
| | Compressive Strength | 1 | 2010 | 70 | 0.020 |
Why?
| | Cell Count | 1 | 2011 | 303 | 0.020 |
Why?
| | Predictive Value of Tests | 1 | 2015 | 1791 | 0.020 |
Why?
| | Particle Size | 1 | 2011 | 317 | 0.020 |
Why?
| | Haplorhini | 1 | 2008 | 57 | 0.020 |
Why?
| | Cross-Sectional Studies | 1 | 2018 | 4400 | 0.020 |
Why?
| | Child, Preschool | 1 | 2020 | 9114 | 0.020 |
Why?
| | Child | 1 | 2020 | 18400 | 0.010 |
Why?
|
|
Kern's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|